| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |